home All News open_in_new Full Article

How automotive exec Crystal Brown founded CircNova, an AI drug discovery biotech

Tiny Michigan biotech startup CircNova has raised a $3.3 million seed round for its technology that uses AI to target so-called “circular RNA.” The development holds promise as a new method to quickly develop therapies for conditions that currently have no drug treatments. The new funding is also a victory lap for co-founder and CEO […] © 2024 TechCrunch. All rights reserved. For personal use only.



Crystal Brown, a former automotive executive, has founded CircNova, a biotech startup using AI to discover new drug therapies targeting circular RNA. The company has secured $3.3 million in seed funding. Brown transitioned from automotive manufacturing to biotech, leveraging her business acumen to enhance life sciences startups. CircNova's NovaEngine, a proprietary AI tool, predicts circular RNA structures and produces molecules for testing, supported by the University of Michigan. Co-founded with scientist Joe DeAngelo, the venture has garnered investor confidence, with backers like Union Heritage Ventures' Nia Batts expressing faith in Brown's entrepreneurial resilience.

today 15 h. ago attach_file Politics

attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Culture
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events


ID: 2567215513
Add Watch Country

arrow_drop_down